Premier Dental in Omaha, Nebraska
-
El Paso health update: Measles exposures posted; prevention funding and drug-access debate in focus
El Paso, TX – March 3, 2026 – City health officials confirmed measles cases and exposure sites, while new grants and policy debates shape care.
-
6 Expert Tips for Dealing with Invisalign Discomfort
Invisalign is a popular orthodontic treatment that involves using a series of clear aligners to gradually straighten teeth. While Invisalign offers numerous benefits, some individuals may experience discomfort during their…
-
Aurora Bay Area Prices – LACERATION REPAIR-COMPLEX is $730
At Aurora Bay Area, we prioritize providing our patients with comprehensive financial information upfront. For Charge Code 10002524, regarding LACERATION REPAIR-COMPLEX, which is classified under revenue code 450 and associated with CPT code , the designated fee stands at $730. Our aim through the CompareMedCosts program is to furnish you with all the details you need to make informed healthcare decisions, offering clarity and transparency around the costs associated with your care.
-
Latest Advances in Neurology in 2025: Treatments Changing Patient Care
In 2025, neurology is shifting toward earlier, more personalized, and less invasive care that meaningfully improves daily life. Blood-based biomarkers and AI-enhanced imaging are speeding diagnosis and helping match patients to the right treatments, while disease‑modifying options are expanding—from anti‑amyloid therapies for Alzheimer’s and genetics‑guided approaches in ALS to next‑generation therapies for MS and new migraine preventives. Targeted neuromodulation and wearable monitoring are reducing symptoms and hospital visits in epilepsy and movement disorders, and stroke care is faster and more effective with streamlined thrombolysis, improved thrombectomy, and home‑based rehabilitation. For patients, caregivers, and information seekers, these advances translate into clearer choices, more care delivered at home, better function with fewer side effects, and greater access to clinical trials when standard options are limited.
